Clik here to view.
MassDevice.com +3 | The top 3 med-tech stories for July 3, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
Sunshine Heart soars on C-Pulse CE Mark | Wall Street Beat
Sunshine Heart (ASX:SHC) is shining on Wall Street today after announcing European regulatory approval for its C-Pulse heart assist system, with SHC shares closing up nearly 14% on the news. The Eden...
View ArticleClik here to view.
Greatbatch slips to loss in Q3 with Swiss plant closure costs
Medical device maker Greatbatch (NYSE:GB) lost $7.6 million in 3Q, the result of the nearly $15 million in expense to close a pair of Swiss factories. The Clarence, N.Y.-based company lost 32¢ per...
View ArticleClik here to view.
AngioDynamics names senior VP & CTO | Personnel Moves
AngioDynamics names new CTOAngioDynamics’ (NSDQ:ANGO) promoted George Bourne to senior vice president and chief technology & operations officer. Bourne in his new role will be responsible for...
View ArticleClik here to view.
Edwards CEO Mussallem details U.S. Sapien sales guidance, updates on...
Edwards Lifesciences (NYSE:EW) chairman & CEO Michael Mussallem said the medical device company expects to post U.S. sales of $390 million-$440 million for its flagship Sapien heart valve, adding...
View ArticleClik here to view.
Greatbatch raises 2013 guidance on restructuring efforts | Wall Street Beat
Texas medical device maker Greatbatch (NYSE:GB) raised its 2013 per-share earnings guidance as it announced new efforts to reorganize some of its business practices and reduce costs as it shifts from...
View ArticleClik here to view.
Greatbatch raises guidance on Q2 figures
Texas medical device maker Greatbatch (NYSE:GB) posted a profit in Q2 and nudged its 2013 per-share earnings guidance up for the 2nd time in 2 months. The device maker’s Q2’s sales eked out a 3% boost...
View ArticleClik here to view.
Uroplasty’s new CFO hails from Synovis | Personnel Moves
Uroplasty (NSDQ:UPI) named Brett Reynolds to head its vacant finance chief position, drawing the new executive from his most recent gig as CFO at Baxter– (NYSE:BAX)acquired Synovis Life Technologies....
View ArticleClik here to view.
Greatbatch gains on Q3 swing to black, earnings beat
Greatbatch (NYSE:GB) shares are up this morning after the medical device company reported a profitable 3rd quarter and beat Wall Street’s expectations for per-share earnings. Frisco, Texas-based...
View ArticleClik here to view.
Greatbatch submits PMA for spinal cord stim
Greatbatch (NYSE:GB) this week filed a pre-market approval application with the FDA for its spinal cord neuromodulation system. The neuromodulation system comes from the Frisco, Texas-based company’s...
View ArticleClik here to view.
Greatbatch requests CE Mark for spinal cord stim
Greatbatch (NYSE:GB) filed a CE Mark application for its spinal cord stimulation system with German notified body TÜV SÜD America. The spinal cord stimulation system comes from Greatbatch’s...
View ArticleClik here to view.
Layoffs ahead as Greatbatch transfers production to Mexico, Massachusetts
Greatbatch (NYSE:GB) said today that it’s planning to shuffle its manufacturing operation, moving some production from Minnesota, Oregon and Massachusetts to plants in Tijuana, Mexico. The moves will...
View ArticleClik here to view.
Sunshine Heart taps Boston Scientific R&D vet for ops role | Personnel Moves
Sunshine Heart (NSDQ:SSH) said it named Brian Brown, a longtime Boston Scientific (NYSE:BSX) R&D veteran, as its new operations & technology vice president. Brown, who was vice president of...
View ArticleClik here to view.
Greatbatch acquires Uruguay’s CCC Medical Devices
Greatbatch (NYSE:GB) said today that it paid an unspecified amount to acquire a Uruguayan medical device company. Montevideo-based CCC Medical Devices makes implantable pulse generators, programmer...
View ArticleClik here to view.
FTC wants more data on MDT-COV deal | Medtech Wall Street news for the week...
FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried August 7, 2014 by Arezu Sarvestani The anti-inversion commotion in Washington, D.C., is “more bark than bite” and unlikely...
View ArticleClik here to view.
Greatbatch mulls spinout for Algostim SCS business
Greatbatch (NYSE:GB) yesterday said it’s looking into a spinout for its Algostim spinal cord stimulator business, which would see the subsidiary become an independent, publicly traded company....
View ArticleClik here to view.
CEO says SNN ‘working hard’ on acquisitions trail | The week in medtech M&A
Smith & Nephew 'working hard' on acquisitions trail, CEO says April 30, 2015 by Brad Perriello Smith & Nephew CEO Olivier Bohuon said that the British healthcare giant is “still working hard”...
View ArticleClik here to view.
Greatbatch Q2 earnings release lifts shares
Greatbatch (NYSE:GB) shares climbed with the announcement of its Q2 results, growing from last year but narrowly missing analysts expectations The Frisco, Texas-based company reported profits of $9.2...
View ArticleClik here to view.
Greatbatch inks deal with WiTricity for wireless med device charging
Greatbatch (NYSE:GB) said today it inked a deal with wireless charging company WiTricty to supply its wireless charging technology to Greatbatch. Through the agreement, Frisco, Texas-based Greatbatch...
View ArticleClik here to view.
Greatbatch to buy out Lake Region Medical for $1.7B
Greatbatch (NYSE:GB) said today that it closed the $1.7 billion cash-and-stock acquisition of Lake Region Medical. Terms call for Frisco, Texas-based Greatbatch to pay $478 million in cash and some 5.1...
View Article
